However, obesity may promote the development of MDD following the activation of pathophysiological mechanisms (inflammation, insulin/leptin resistance, and hypertension) with a negative impact on the neuroimmune status and the neural circuits controlling mood/emotional states [49]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.